"These catalogues are going to change the way we think about individual cancers," said Professor Michael Stratton, of the Wellcome Trust in Great Britain.
"By identifying all the cancer genes we will be able to develop new drugs that target the specific mutated genes and work out which patients will benefit from these novel treatments," he said. "We can envisage a time when following the removal of a cancer, cataloguing it will become routine."
Copyright © 2011 HealthDay. All rights reserved.